• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Holdco Nuvo Group D.G Ltd.

    8/23/24 5:15:11 PM ET
    $NUVO
    Medical/Dental Instruments
    Health Care
    Get the next $NUVO alert in real time by email
    6-K 1 holdconuvo_6k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington D.C. 20549

     

     

     

    FORM 6-K

     

     

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13-a16 OR 15-d16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of August 2024

     

    Commission File Number: 001-42038

     

     

     

    Holdco Nuvo Group D.G Ltd.

    (Translation of registrant’s name into English)

     

     

     

    94 Yigal Alon St.

    Tel Aviv, Israel 6789155

    (Address of principal executive offices)

     

     

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x Form 40-F ¨

     

     

     

       

     

     

    As previously disclosed, on August 22, 2024, the Company with certain of its direct and indirect subsidiaries filed voluntary petitions for relief (the “Chapter 11 Cases”) under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).

     

    On August 22, 2024, the Company received written notice (the “Delisting Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that the Company’s ordinary shares and warrants will be delisted from Nasdaq. The Delisting Notice also advises the Company of its right to appeal Nasdaq’s determination pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. The Company does not intend to pursue an appeal.

     

    Trading of the Company’s ordinary shares and warrants will be suspended at the opening of business on September 3, 2024. Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s ordinary shares and warrants from listing and registration on Nasdaq. As a result, the Company’s ordinary shares and warrants are expected to commence trading on the Pink Open Market operated by the OTC Markets Group, Inc. (commonly referred to as the “pink sheets”). The Pink Open Market is a significantly more limited market than the Nasdaq, and quotation on the Pink Open Market will likely result in a less liquid market for existing and potential holders of the Company’s ordinary shares and warrants to trade and could further depress the trading price of the Company’s ordinary shares and warrants. The Company can provide no assurance that its ordinary shares or warrants will continue to trade on this market, whether broker-dealers will continue to provide public quotes of the Company’s ordinary shares or warrants on this market, or whether the trading volume of the Company’s ordinary shares and warrants will be sufficient to provide for an efficient trading market for existing and potential holders thereof.

     

     1 

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Holdco Nuvo Group D.G Ltd.
         
    Date: August 23, 2024 By: /s/ Robert Powell
        Name: Robert Powell
        Title: Chief Executive Officer

     

     2 

     

    Get the next $NUVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NUVO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NUVO
    SEC Filings

    See more
    • SEC Form 6-K filed by Holdco Nuvo Group D.G Ltd.

      6-K - Holdco Nuvo Group D.G Ltd. (0001990145) (Filer)

      9/18/24 3:00:12 PM ET
      $NUVO
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Holdco Nuvo Group D.G Ltd.

      6-K - Holdco Nuvo Group D.G Ltd. (0001990145) (Filer)

      8/23/24 5:15:11 PM ET
      $NUVO
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Holdco Nuvo Group D.G Ltd.

      6-K - Holdco Nuvo Group D.G Ltd. (0001990145) (Filer)

      8/22/24 1:20:48 PM ET
      $NUVO
      Medical/Dental Instruments
      Health Care

    $NUVO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ATTENTION DIRECT AND INDIRECT HOLDERS OF SECURITIES ISSUED BY HOLDCO NUVO GROUP D.G LTD.: The United States Bankruptcy Court for the District of Delaware has entered an order that imposes substantial restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates

      WILMINGTON, Del., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd. has issued the following announcement related to trading in equity interests in the Company: The United States Bankruptcy Court for the District of Delaware has entered an order that imposes substantial restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates.   A copy of the order may be found at the following internet address: http://dm.epiq11.com/NuvoGroup; questions regarding the order may be directed to proposed claims and noticing agent Epiq Corporate Restructuring, LLC or proposed counsel for Debtors, Hughes Hubbard & Reed LLP, One Battery Park Plaza, New York, Ne

      9/4/24 11:13:50 PM ET
      $NUVO
      Medical/Dental Instruments
      Health Care